How much funding has Colossal Biosciences raised?

Colossal Biosciences has raised $583.0M in total funding, most recently a Venture Round.

Who are Colossal Biosciences's investors?

Colossal Biosciences's investors include Tulco, TWG Global, At One Ventures, USIT, Bob Nelsen, Peter Jackson.

When was Colossal Biosciences founded?

Colossal Biosciences was founded in 2021.

Where is Colossal Biosciences headquartered?

Colossal Biosciences is headquartered in Dallas, Texas, United States.

What industry is Colossal Biosciences in?

Colossal Biosciences operates in Biotech, Genetics.

How many employees does Colossal Biosciences have?

Colossal Biosciences has 51-200 employees.

Colossal Biosciences

The science of genetics. The business of discovery.

Dallas, United States · Founded 2021 · $583.0M raised

Biotech

Genetics

Headquarters: Dallas, Texas
Employees: 51–200
Founded: 2021
Business Model: Other

Website: colossal.com
Total Funding: $583.0M
Last Round: $23.0M Venture RoundSep 2025
Rounds: 7

About

Colossal Biosciences is a de-extinction company using genetic engineering to resurrect woolly mammoths, thylacines, dodos and other species. Founded by Ben Lamm and George Church, it advances genomics for ecosystem restoration and conservation.

Summary

Colossal Biosciences is a Biotech company based in Dallas, United States, founded in 2021. It has raised $583.0M in total across 7 rounds, most recently a $23.0M Venture Round round in Sep 2025. Investors include Tulco, TWG Global and At One Ventures.

LinkedIn X (Twitter)